Innovations Spotlight

For media inquiries, please contact Susan Bernat – 216.312.4369

COVID-19: Vaccines, Myths, & Masks

01/19/2021

COVID-19: Vaccines, Myths, & Masks

Following Emergency Use Authorization (EUA) from the FDA of COVID-19 vaccines in mid-December, Cleveland Clinic began its distribution of the limited doses received. Vaccinating according to a phased approach, with focus on frontline, inpatient-facing caregivers, the enterprise has worked overtime to distribute vaccines safely, equitably, and transparently while preserving the ability to maintain critical clinical operations.
 


Top 10 for 2021: #1 | Gene Therapy for Hemoglobinopathies

01/13/2021

Top 10 for 2021: #1 | Gene Therapy for Hemoglobinopathies

Living with a condition with no known cure is the devastating reality for those patients suffering from these genetic disorders. Hemoglobin disorders, or hemoglobinopathies, arise when an individual's beta-globin gene is dysfunctional. The most common hemoglobinopathies include sickle cell disease and thalassemia – combined, affecting an estimated 330,000 kids born worldwide every year.


With Bated Breath: Awaiting New Diagnostic Measures for COVID-19

01/12/2021

With Bated Breath: Awaiting New Diagnostic Measures for COVID-19

Leveraging the ability to measure compounds in the breath known as volatile organic compounds, a team at Cleveland Clinic has developed a breath analysis test to capture vapor droplets and indicate the presence of particular compounds for the diagnosis of COVID-19.


Top 10 for 2021: #2 | Novel Drug for Primary Progressive Multiple Sclerosis

01/04/2021

Top 10 for 2021: #2 | Novel Drug for Primary Progressive Multiple Sclerosis

Multiple sclerosis is not a single disease. The majority of patients – around 85% – suffer from relapsing-remitting MS. Which means they may experience disappearing and reappearing symptoms. In contrast, patients suffering from a less common primary progressive multiple sclerosis have a continuously worsening disease from the time of diagnosis.


Year in Review from Innovation at Cleveland Clinic

12/22/2020

Year in Review from Innovation at Cleveland Clinic

Approaching the end of a year with unprecedented twists and turns, we’re sure you’re in no way short of a library of reflection pieces. And though our final 2020 recap might throw another on the pile, as a health organization battling the pandemic first hand, innovating to bring solutions to light, and investing to be the change healthcare needs, we’d be remiss to not share our thoughts with this community – our lessons learned from being, and supporting, the frontline.


Top 10 for 2021: #3 | Smartphone-Connected Pacemaker Devices

12/21/2020

Top 10 for 2021: #3 | Smartphone-Connected Pacemaker Devices

Convenient and accurate, this newest advancement in cardiac medical technology increases the connection between patient and treatment. While millions of people rely on surgically implanted devices like pacemakers to keep them alive, clinical monitoring is critical and, until now, has only been one-sided.


Top 10 for 2021: #4 | New Medication for Cystic Fibrosis

12/18/2020

Top 10 for 2021: #4 | New Medication for Cystic Fibrosis

Passing a hereditary disease to a child is one of a parent's worst fears. Although uncontrollable, one in every 35 Americans, is born with a defective cystic fibrosis, or CF, gene. With CF, mutations in the cystic fibrosis transmembrane conductance regulator, or CFTR gene, cause the CFTR protein to become dysfunctional, making it unable to help move chloride to the surface of the cells in the body.


MIS2020 Recap: Session 4

12/17/2020

MIS2020 Recap: Session 4

Whether you joined us live on October 6, watched content On Demand, or have yet to engage with the 2020 Medical Innovation Summit by Cleveland Clinic, the learning opportunity remains as we continue to host recordings of the live event on our interactive platform. Access to these recordings, however, expires 12/31 – sign in or register today to view them before they’re gone


Top 10 for 2021: #5: Universal Hepatitis C Treatment

12/16/2020

Top 10 for 2021: #5: Universal Hepatitis C Treatment

Classified as a silent epidemic by the CDC, more than 3.2 million Americans are infected with Hepatitis C, and as many as 75% are unaware they carry the virus. Spreading through contact with blood from an infected person, Hepatitis C is a virus that causes liver inflammation that can result in liver failure or cancer. Currently, there are no vaccines to prevent Hepatitis C infection.
 


Watch Now! Small but Mighty: Startup Contributions in COVID-19

12/15/2020

Watch Now! Small but Mighty: Startup Contributions in COVID-19

On December 1, as part of our December Transformation Tuesdays Investment & Startup Industry series, Founders and CEOs of some remarkable startups joined us to discuss their contributions in COVID-19. While startups are often viewed as fragile, risky investments, true innovators know the potential these young organizations hold.


  < 1 2 3 4 5 6 7 8 9 10  > 

Get In Touch With Us